List of Tables
Table 1. Heparin Market Trends
Table 2. Heparin Market Drivers & Opportunity
Table 3. Heparin Market Challenges
Table 4. Heparin Market Restraints
Table 5. Global Heparin Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Heparin Revenue Market Share by Company (2019-2024)
Table 7. Global Heparin Sales Volume by Company (2019-2024) & (B Units)
Table 8. Global Heparin Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Heparin Price by Company (2019-2024) & (US$/B Units)
Table 10. Key Manufacturers Heparin Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Heparin Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Heparin
Table 13. Global Heparin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Heparin Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Heparin Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Heparin Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Heparin Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Heparin Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Heparin Sales Volume by Type: 2019 VS 2023 VS 2030 (B Units)
Table 22. Global Heparin Sales Volume by Type (2019-2024) & (B Units)
Table 23. Global Heparin Sales Volume by Type (2025-2030) & (B Units)
Table 24. Global Heparin Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Heparin Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Heparin Price by Type (2019-2024) & (US$/B Units)
Table 27. Global Heparin Price by Type (2025-2030) & (US$/B Units)
Table 28. Global Heparin Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Heparin Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Heparin Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Heparin Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Heparin Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Heparin Sales Volume by Application: 2019 VS 2023 VS 2030 (B Units)
Table 34. Global Heparin Sales Volume by Application (2019-2024) & (B Units)
Table 35. Global Heparin Sales Volume by Application (2025-2030) & (B Units)
Table 36. Global Heparin Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Heparin Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Heparin Price by Application (2019-2024) & (US$/B Units)
Table 39. Global Heparin Price by Application (2025-2030) & (US$/B Units)
Table 40. Global Heparin Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Heparin Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Heparin Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Heparin Sales Value by Region (2019-2024) & (%)
Table 44. Global Heparin Sales Value by Region (2025-2030) & (%)
Table 45. Global Heparin Sales Volume by Region (B Units): 2019 VS 2023 VS 2030
Table 46. Global Heparin Sales Volume by Region (2019-2024) & (B Units)
Table 47. Global Heparin Sales Volume by Region (2025-2030) & (B Units)
Table 48. Global Heparin Sales Volume by Region (2019-2024) & (%)
Table 49. Global Heparin Sales Volume by Region (2025-2030) & (%)
Table 50. Global Heparin Average Price by Region (2019-2024) & (US$/B Units)
Table 51. Global Heparin Average Price by Region (2025-2030) & (US$/B Units)
Table 52. Key Countries/Regions Heparin Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Heparin Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Heparin Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Heparin Sales Volume, (2019-2024) & (B Units)
Table 56. Key Countries/Regions Heparin Sales Volume, (2025-2030) & (B Units)
Table 57. Shenzhen Hepalink Pharmaceutical Company Information
Table 58. Shenzhen Hepalink Pharmaceutical Introduction and Business Overview
Table 59. Shenzhen Hepalink Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2019-2024)
Table 60. Shenzhen Hepalink Pharmaceutical Heparin Product Offerings
Table 61. Shenzhen Hepalink Pharmaceutical Recent Development
Table 62. Yantai Dongcheng Pharmaceutical Company Information
Table 63. Yantai Dongcheng Pharmaceutical Introduction and Business Overview
Table 64. Yantai Dongcheng Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2019-2024)
Table 65. Yantai Dongcheng Pharmaceutical Heparin Product Offerings
Table 66. Yantai Dongcheng Pharmaceutical Recent Development
Table 67. Pfizer Company Information
Table 68. Pfizer Introduction and Business Overview
Table 69. Pfizer Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2019-2024)
Table 70. Pfizer Heparin Product Offerings
Table 71. Pfizer Recent Development
Table 72. Bioibérica Company Information
Table 73. Bioibérica Introduction and Business Overview
Table 74. Bioibérica Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2019-2024)
Table 75. Bioibérica Heparin Product Offerings
Table 76. Bioibérica Recent Development
Table 77. Changzhou Qianhong Biopharma Company Information
Table 78. Changzhou Qianhong Biopharma Introduction and Business Overview
Table 79. Changzhou Qianhong Biopharma Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2019-2024)
Table 80. Changzhou Qianhong Biopharma Heparin Product Offerings
Table 81. Changzhou Qianhong Biopharma Recent Development
Table 82. Nanjing King-friend Biochemical Pharmaceutical Company Information
Table 83. Nanjing King-friend Biochemical Pharmaceutical Introduction and Business Overview
Table 84. Nanjing King-friend Biochemical Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2019-2024)
Table 85. Nanjing King-friend Biochemical Pharmaceutical Heparin Product Offerings
Table 86. Nanjing King-friend Biochemical Pharmaceutical Recent Development
Table 87. Hebei Changshan Biochemical Pharmaceutical Company Information
Table 88. Hebei Changshan Biochemical Pharmaceutical Introduction and Business Overview
Table 89. Hebei Changshan Biochemical Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2019-2024)
Table 90. Hebei Changshan Biochemical Pharmaceutical Heparin Product Offerings
Table 91. Hebei Changshan Biochemical Pharmaceutical Recent Development
Table 92. Qingdao Jiulong Biopharmaceutical Company Information
Table 93. Qingdao Jiulong Biopharmaceutical Introduction and Business Overview
Table 94. Qingdao Jiulong Biopharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2019-2024)
Table 95. Qingdao Jiulong Biopharmaceutical Heparin Product Offerings
Table 96. Qingdao Jiulong Biopharmaceutical Recent Development
Table 97. Opocrin Company Information
Table 98. Opocrin Introduction and Business Overview
Table 99. Opocrin Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2019-2024)
Table 100. Opocrin Heparin Product Offerings
Table 101. Opocrin Recent Development
Table 102. Dongying Tiandong Pharmaceutical Company Information
Table 103. Dongying Tiandong Pharmaceutical Introduction and Business Overview
Table 104. Dongying Tiandong Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2019-2024)
Table 105. Dongying Tiandong Pharmaceutical Heparin Product Offerings
Table 106. Dongying Tiandong Pharmaceutical Recent Development
Table 107. Aspen Oss Company Information
Table 108. Aspen Oss Introduction and Business Overview
Table 109. Aspen Oss Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2019-2024)
Table 110. Aspen Oss Heparin Product Offerings
Table 111. Aspen Oss Recent Development
Table 112. Yino Pharma Company Information
Table 113. Yino Pharma Introduction and Business Overview
Table 114. Yino Pharma Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2019-2024)
Table 115. Yino Pharma Heparin Product Offerings
Table 116. Yino Pharma Recent Development
Table 117. Nanjing Xinbai Pharmaceutical Company Information
Table 118. Nanjing Xinbai Pharmaceutical Introduction and Business Overview
Table 119. Nanjing Xinbai Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2019-2024)
Table 120. Nanjing Xinbai Pharmaceutical Heparin Product Offerings
Table 121. Nanjing Xinbai Pharmaceutical Recent Development
Table 122. Hubei Enoray Biopharmaceutical Company Information
Table 123. Hubei Enoray Biopharmaceutical Introduction and Business Overview
Table 124. Hubei Enoray Biopharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2019-2024)
Table 125. Hubei Enoray Biopharmaceutical Heparin Product Offerings
Table 126. Hubei Enoray Biopharmaceutical Recent Development
Table 127. Cisen Pharmaceutical Company Information
Table 128. Cisen Pharmaceutical Introduction and Business Overview
Table 129. Cisen Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (US$/B Units) and Gross Margin (2019-2024)
Table 130. Cisen Pharmaceutical Heparin Product Offerings
Table 131. Cisen Pharmaceutical Recent Development
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Heparin Downstream Customers
Table 135. Heparin Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Heparin Product Picture
Figure 2. Global Heparin Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Heparin Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Heparin Sales Volume (2019-2030) & (B Units)
Figure 5. Global Heparin Sales Price (2019-2030) & (US$/B Units)
Figure 6. Heparin Report Years Considered
Figure 7. Global Heparin Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Heparin Players Sales Volume Ranking (2023) & (B Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Heparin Revenue in 2023
Figure 10. Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Heparin Sodium Picture
Figure 12. Heparin Calcium Picture
Figure 13. Global Heparin Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Heparin Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Heparin Sales Volume by Type (2019 VS 2023 VS 2030) & (B Units)
Figure 16. Global Heparin Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Heparin Price by Type (2019-2030) & (US$/B Units)
Figure 18. Product Picture of UFH
Figure 19. Product Picture of LMWH
Figure 20. Global Heparin Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Heparin Sales Value Market Share by Application, 2023 & 2030
Figure 22. Global Heparin Sales Volume by Application (2019 VS 2023 VS 2030) & (B Units)
Figure 23. Global Heparin Sales Volume Market Share by Application, 2023 & 2030
Figure 24. Global Heparin Price by Application (2019-2030) & (US$/B Units)
Figure 25. North America Heparin Sales Value (2019-2030) & (US$ Million)
Figure 26. North America Heparin Sales Value by Country (%), 2023 VS 2030
Figure 27. Europe Heparin Sales Value (2019-2030) & (US$ Million)
Figure 28. Europe Heparin Sales Value by Country (%), 2023 VS 2030
Figure 29. Asia Pacific Heparin Sales Value (2019-2030) & (US$ Million)
Figure 30. Asia Pacific Heparin Sales Value by Country (%), 2023 VS 2030
Figure 31. South America Heparin Sales Value (2019-2030) & (US$ Million)
Figure 32. South America Heparin Sales Value by Country (%), 2023 VS 2030
Figure 33. Middle East & Africa Heparin Sales Value (2019-2030) & (US$ Million)
Figure 34. Middle East & Africa Heparin Sales Value by Country (%), 2023 VS 2030
Figure 35. Key Countries/Regions Heparin Sales Value (%), (2019-2030)
Figure 36. Key Countries/Regions Heparin Sales Volume (%), (2019-2030)
Figure 37. United States Heparin Sales Value, (2019-2030) & (US$ Million)
Figure 38. United States Heparin Sales Value by Type (%), 2023 VS 2030
Figure 39. United States Heparin Sales Value by Application (%), 2023 VS 2030
Figure 40. Europe Heparin Sales Value, (2019-2030) & (US$ Million)
Figure 41. Europe Heparin Sales Value by Type (%), 2023 VS 2030
Figure 42. Europe Heparin Sales Value by Application (%), 2023 VS 2030
Figure 43. China Heparin Sales Value, (2019-2030) & (US$ Million)
Figure 44. China Heparin Sales Value by Type (%), 2023 VS 2030
Figure 45. China Heparin Sales Value by Application (%), 2023 VS 2030
Figure 46. Japan Heparin Sales Value, (2019-2030) & (US$ Million)
Figure 47. Japan Heparin Sales Value by Type (%), 2023 VS 2030
Figure 48. Japan Heparin Sales Value by Application (%), 2023 VS 2030
Figure 49. South Korea Heparin Sales Value, (2019-2030) & (US$ Million)
Figure 50. South Korea Heparin Sales Value by Type (%), 2023 VS 2030
Figure 51. South Korea Heparin Sales Value by Application (%), 2023 VS 2030
Figure 52. Southeast Asia Heparin Sales Value, (2019-2030) & (US$ Million)
Figure 53. Southeast Asia Heparin Sales Value by Type (%), 2023 VS 2030
Figure 54. Southeast Asia Heparin Sales Value by Application (%), 2023 VS 2030
Figure 55. India Heparin Sales Value, (2019-2030) & (US$ Million)
Figure 56. India Heparin Sales Value by Type (%), 2023 VS 2030
Figure 57. India Heparin Sales Value by Application (%), 2023 VS 2030
Figure 58. Heparin Industrial Chain
Figure 59. Heparin Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
